Arzneiwerk AG VIDA

NEW
XTER:TLIK (Germany)  
€ 0.52 +0.050 (+10.64%) Feb 27
At Loss
Market Cap:
€ 2.68M ($ 2.79M)
Enterprise V:
€ 13.21M ($ 13.77M)
Volume:
50.00
Avg Vol (2M):
1.01K
Trade In:

Business Description

Description
Arzneiwerk AG VIDA is active in the pharmaceutical industry. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry. The company focuses on the growth area of specialty pharma in Germany and Europe which usually includes high-priced drugs for chronic, complex, or rare diseases such as oncology, neurology, autoimmune diseases, ophthalmology, hemophilia, and infectious diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 0.09
Equity-to-Asset -0.41
Debt-to-Equity -2.34
Debt-to-EBITDA -23
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.43
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -25.4
3-Year EPS without NRI Growth Rate -132.9

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 62.95
9-Day RSI 56.38
14-Day RSI 51.22
3-1 Month Momentum % -25.34
6-1 Month Momentum % -42.63
12-1 Month Momentum % -52.19

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.63
Quick Ratio 0.26
Cash Ratio 0.07
Days Inventory 8343.56
Days Sales Outstanding 141.69
Days Payable 2030.75

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.6
Shareholder Yield % 65.2

Financials

XTER:TLIK's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Arzneiwerk AG VIDA Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 2.068
EPS (TTM) (€) -0.195
Beta 0.5
3-Year Sharpe Ratio -1.45
3-Year Sortino Ratio -1.63
Volatility % 28.86
14-Day RSI 51.22
14-Day ATR (€) 0.032569
20-Day SMA (€) 0.48835
12-1 Month Momentum % -52.19
52-Week Range (€) 0.4 - 1.23
Shares Outstanding (Mil) 6.23

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Arzneiwerk AG VIDA Filings

Filing Date Document Date Form
No Filing Data

Arzneiwerk AG VIDA Stock Events

Financials Calendars
Event Date Price (€)
No Event Data

Arzneiwerk AG VIDA Frequently Asked Questions

What is Arzneiwerk AG VIDA(XTER:TLIK)'s stock price today?
The current price of XTER:TLIK is €0.52. The 52 week high of XTER:TLIK is €1.23 and 52 week low is €0.40.
When is next earnings date of Arzneiwerk AG VIDA(XTER:TLIK)?
The next earnings date of Arzneiwerk AG VIDA(XTER:TLIK) is .
Does Arzneiwerk AG VIDA(XTER:TLIK) pay dividends? If so, how much?
Arzneiwerk AG VIDA(XTER:TLIK) does not pay dividend.

Press Release

Subject Date
No Press Release